Prognostic value of percutaneous coronary intervention for heart failure with mid-range ejection fraction

The updated classification of heart failure ESC 2016 highlights new problems of understanding epidemiology and treatment of the syndrome. In particular, today there is a lack of prognostically advantageous management of patients with heart failure with preserved or midrange left ventricular ejection fraction (HFpEF/HFmrEF). Even less information exists regarding long-term outcomes after the application of percutaneous coronary intervention (PCI) in these patients. There is only a small amount of studies about the long-term prognosis after PCI with stratification on values of LVEF Their results are analyzed in this article and make it possible to indirectly judge the effectiveness of this method in the group of patients with HFmrEF